Illumina Outside the United States — Concentration percent remained flat by 0.0% to 13.3% in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 13.3% to 13.3%. Over 4 years (FY 2021 to FY 2025), Outside the United States — Concentration percent shows relatively stable performance with a 0.5% CAGR.
An increase suggests growing international market share or successful global expansion, while a decrease indicates a higher reliance on the domestic market or potential challenges in international sales channels.
This metric represents the proportion of total consolidated revenue generated from geographic regions outside of the com...
Global life science and technology firms typically report international revenue concentration to highlight their exposure to emerging markets versus mature domestic economies.
ilmn_segment_outside_the_united_states_concentration_percent| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | 52% | 54% | 55% | 53% | 53% |
| YoY Change | — | +3.8% | +1.9% | -3.6% | +0.0% |